Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)Hideki Kato, Ichiei Narita, Terumasa Hayashi et al.|Clinical and Experimental Nephrology|2017Cited by 20
Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in JapanTerumasa Hayashi, Ichiei Narita, Hideki Kato et al.|Clinical and Experimental Nephrology|2020Cited by 15